Multifocal Motor Neuropathy (MMN), Progressive Muscle Disorder

Pathogenesis and Mechanism of Action of Inflammatory Neuropathies

Richard A. Lewis, MD

Cedars-Sinai Medical Center, Los Angeles, CA, USA

13:53 MIN

CIDP
GBS
MMN

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

Nabil Moumane, MD

Medical Affairs and Pharmacology, CSL Behring

3:00 MIN

CIDP
MMN

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

Global Multifocal Motor Neuropathy Quality of Life Patient Survey

Jonathan S. Katz, MD

Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California

09:51 MIN

Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.

SCIg in Multifocal Motor Neuropathy

Hans D. Katzberg, MD, MSc, FRCP(C)

University Health Network /Toronto General Hospital Canada

10:32 MIN

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

NOW PLAYING

13:53

Pathogenesis and Mechanism of Action of Inflammatory Neuropathies

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

NOW PLAYING

3:00

Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic...

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

NOW PLAYING

09:51

Global Multifocal Motor Neuropathy Quality of Life Patient Survey

Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.

NOW PLAYING

10:32

SCIg in Multifocal Motor Neuropathy

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

Our Experts on MMN

VIEW ALL EXPERTS

Richard A. Lewis, MD

Cedars-Sinai Medical Center, Los Angeles, CA, USA

Richard A. Lewis, MD

Cedars-Sinai Medical Center, Los Angeles, CA, USA

CIDP
GBS
MMN

Richard A. Lewis, MD is Professor of Neurology at Cedars-Sinai Medical Center in Los Angeles, California where he directs the EMG laboratory and co-directs the neuromuscular clinical program.

Jonathan S. Katz, MD

Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California

Jonathan S. Katz, MD

Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California

Jonathan S. Katz, MD, is the Director, Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California.

Nabil Moumane, MD

Medical Affairs and Pharmacology, CSL Behring

Nabil Moumane, MD

Medical Affairs and Pharmacology, CSL Behring

CIDP
MMN

Nabil Moumane is the Director of Medical Affairs and Pharmacology at CSL Behring.

Hans D. Katzberg, MD, MSc, FRCP(C)

University Health Network /Toronto General Hospital Canada

Hans D. Katzberg, MD, MSc, FRCP(C)

University Health Network /Toronto General Hospital Canada

Dr. Hans Katzberg is a neuromuscular specialist and clinical investigator at the University Health Network / Toronto General Hospital and has been on faculty at the University of Toronto as Assistant Professor of Neurology.

What is Multifocal Motor Neuropathy (MMN)?

What are the symptoms of MMN?

How is MMN treated?